B. Braun integrates Infusomat Space pump with Epic’s EMR system

B. Braun Medical said today it completed system integrations of its Infusomat Space Pump with Epic’s integrated EMR system. The Bethlehem, Penn.-based company said it used IHE standard communication protocols and transactions for the integration, and cooperated with Epic to test and validate the functionality of its AutoComplete feature. “Through B. Braun’s Infusomat pump and

The first step to navigating your combination product’s regulatory pathway: PMOA

Editor’s Note: This article is written by Winston Brown, VP of Global Quality & Regulatory Affairs at Phillips-Medisize. The drug-device combination product market is growing at a rapid pace. By 2019, it is expected that the global market for drug device combination products will reach $115.1 billion. This is nearly double its worth from $66

Microneedle technology and transdermal drug delivery

Although the figure for the growth of the transdermal drug delivery market is impressive–annual sales are expected to meet 485 million units by 2030–it’s not necessarily a surprise for those close to the industry. Transdermal drug delivery is the perfect blend of medicine and technology for a preferred alternative to conventional vaccine delivery. A subset

Phillips-Medisize to present at the DPI conference in London

Phillips-Medisize Corporation’s Chief Technology Officer, Bill Welch, will present at this week’s Dry Powder Inhalers (DPI) Conference in London. The Dry Powder Inhaler Conference is a key event for pharmaceutical and medical device professionals in the DPI market. The conference presents the latest technology in DPI formulation and development, along with where the DPI market is going

Swiss researchers initiate the vascular bypass revolution

Coronary or peripheral bypasses are the most frequently performed vascular operations. Although one million patients per year and around the world, undergo this intervention, its failure rate reaches 50%, because of poor vessel healing, leading to vessel graft occlusion. To improve the outcome of bypasses, researchers from the University of Geneva (UNIGE) work together with

TissueGen to showcase ELUTE Fiber at MD&M East 2016

TissueGen will present how ELUTE fiber enables medical device developers to achieve breakthroughs across a broad range of medical applications at MD&M East 2016. TissueGen enables controlled sustained delivery of sensitive pharmaceuticals and biologics from biodegradable fibers for advanced drug delivery, nerve regeneration and tissue engineering. TissueGen representatives will be at the show to discuss

Phillips-Medisize buys drug-delivery-device focused developer Medicom

Phillips-Medisize said today it bought drug-delivery device focused device strategy, product design and development service group Medicom Innovation Partner for an undisclosed amount. The acquisition will allow Phillips-Medisize to improve its drug delivery device development, and will expand the company’s end-to-end injectable and inhalation device innovation service solutions, the company said. “This transaction is consistent

Australian pharmacy develops disposable drug delivery pump

South Australian business CPIE Pharmacy Services is preparing to trial prototypes of a single use, portable, electronic drug delivery pump specifically designed for the “Hospital in the Home” sector. CPIE General Manager Andrew Sluggett said the compact pumps would be able to deliver various infusions including antibiotics, chemotherapy drugs, post-operative pain relief and rheumatoid arthritis

Hot melt extruded and injection moulded drug delivery forms articles

Hot melt extrusion (HME) and injection moulding (IM) are becoming more prevalent in the drug delivery field due to their advantages over current pharmaceutical manufacturing techniques. Recently released article from Bentham Science Publishers provides an in-depth analysis into these methods of drug delivery. HME is a continuous process that can be used in the pharmaceutical industry

B. Braun to help nurses in drug disposal safety training

Infusion therapy expert, B. Braun Medical Inc is focusing on awareness and education of USP <800> compliance and the handling of hazardous drugs in healthcare settings at this year’s Oncology Nursing Society Annual Congress. “The new USP < 800 > will require the use of a closed-system drug transfer device for administration when the dosage

Real drug or counterfeit? TruTag Technologies reader & edible barcode can tell

TruTag Technologies Inc. had developed an innovative, edible product security solution that addresses the trillion-dollar global counterfeit problem. At a recent event, TruTag Director of Business Development Steven Yoder presented on the latest advancements in security features for food and drug packaging entitled:  “Going Beyond the Package:  What’s Next in Food and Pharmaceutical Security.” TruTag Technologies

Lubrizol LifeSciences adds commercial manufacturing capacity at Particle Sciences

The Lubrizol Corporation’s LifeSciences, the leading contract development and manufacturing organization (CDMO) for complex drug products, is adding commercial drug product manufacturing capacity at its Particle Sciences facility in Bethlehem, PA. The 18,000 square foot capacity will include both sterile and non-sterile space with complete lyophilization and filling operations.  Among other things, the facility will

BIOCORP accelerates its business development

BIOCORP, a French company specializing in the development and manufacturing of innovative medical and drug delivery devices, announced today the acceleration of its connected devices developments in collaboration with several international pharmaceutical laboratories enhancing therefore Its expertise in e-health via two connected devices: DataPen and Easylog. “These latest developments confirm the relevance of our strategy based on breakthrough technologies as illustrated by the development of

Futurist Ray Kurzweil predicts printed organs, nanorobots, and connecting our brains to computers in the cloud

Futurist Ray Kurzweil made a thought-provoking presentation at the recent MD&M in Anaheim, a trade show for medical device companies. His presentation dealt with the accelerating rate of technical progress, predicting the future, and the human life span. Let’s start with one of his discoveries, that the technical future is predictable and with good precision,

Laser surgery opens blood-brain barrier to chemotherapy

Using a laser probe, neurosurgeons at Washington University School of Medicine in St. Louis have opened the brain’s protective cover, enabling them to deliver chemotherapy drugs to patients with a form of deadly brain cancer. In a pilot study, 14 patients with glioblastoma—the most common and aggressive type of brain cancer—underwent minimally invasive laser surgery